Methylphenidate clinical trials
Also written Ritalin, Concerta, OROS MPH and PRC-063.
How each study uses Methylphenidate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Methylphenidate studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 5 Dec 1955 · RITALIN · NDA 010187 (FDA, Drugs@FDA)
- European Union
- 28 Feb 2025 · Tuzulby · EMEA/H/C/005975 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
318 studies that test it; most in 2014 (26); 2 more planned to start later
| Year | Studies |
|---|---|
| 1997 | 2 |
| 1998 | 4 |
| 1999 | 4 |
| 2000 | 2 |
| 2001 | 6 |
| 2002 | 8 |
| 2003 | 11 |
| 2004 | 13 |
| 2005 | 12 |
| 2006 | 19 |
| 2007 | 21 |
| 2008 | 16 |
| 2009 | 11 |
| 2010 | 17 |
| 2011 | 10 |
| 2012 | 14 |
| 2013 | 18 |
| 2014 | 26 |
| 2015 | 10 |
| 2016 | 12 |
| 2017 | 8 |
| 2018 | 13 |
| 2019 | 11 |
| 2020 | 6 |
| 2021 | 6 |
| 2022 | 7 |
| 2023 | 11 |
| 2024 | 9 |
| 2025 | 4 |
| 2026 | 7 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 57 · Other 267
Massachusetts General Hospital (16) · M.D. Anderson Cancer Center (10) · Rhodes Pharmaceuticals, L.P. (9) · Noven Therapeutics (8) · Shalvata Mental Health Center (7) · Icahn School of Medicine at Mount Sinai (6) · Children's Hospital Medical Center, Cincinnati (6) · New York State Psychiatric Institute (6)
Often tested with
Tested in the same studies.
Atomoxetine (11) · Modafinil (10) · N-Methyl-3,4-methylenedioxyamphetamine (4) · Reboxetine (4) · Guanfacine (4) · Lisdexamfetamine (4) · Caffeine (4) · Carbidopa, levodopa drug combination (3)
Related medicines
As reviewed, each with the page that says it.
- One of Stimulants source
- Dexmethylphenidate is one of its enantiomers, counted on its own page source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 9, 2 in phase 3
Studies that test Methylphenidate, phase 3 first.
- Dec 2026A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 ImmunotherapyPhase 3 · M.D. Anderson Cancer Center
- Feb 2027Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced CancerPhase 2/3 · M.D. Anderson Cancer Center
- Dec 2026rTMS for Apathy Clinical TrialNot applicable · Sunnybrook Health Sciences Centre
- Dec 2026Oxygen Toxicity: Mechanisms in HumansNot applicable · Duke University
- Mar 2027Methylphenidate for the Treatment of PTSD With Associated Neurocognitive ComplaintsPhase 4 · VA Office of Research and Development
- Jul 2027Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell DiseasePhase 1 · St. Jude Children's Research Hospital
- Jul 2027Evaluation of Foquest in Adults 65 Years and Older With ADHDPhase 4 · Dar Clinical Research Inc.
- Aug 2027The Psychiatric and Cognitive Phenotypes in Velocardiofacial SyndromePhase 4 · The Chaim Sheba Medical Center
- Oct 2027Combined Brain Stimulation and Methylphenidate Treatment for Apathy in DementiaPhase 2 · Sunnybrook Health Sciences Centre
Studies
Open first, then newest update. How each study uses Methylphenidate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 324
- Methylphenidate for the Treatment of Epilepsy-related Cognitive DeficitsRecruitingPhase 4VA Office of Research and DevelopmentNCT04419272Written as Methylphenidate
- A Multimodal Imaging Study of Dopamine in Early PsychosisNot yet recruitingPhase 1New York State Psychiatric InstituteNCT06977308Written as Methylphenidate (MPH)
- Methylphenidate in Pediatric Brain Tumor Survivors With Cancer-related FatigueRecruitingPhase 3Odense University HospitalNCT06905587Written as Methylphenidate (MPH)
- Written Exposure Therapy Plus Adjunctive Methylphenidate Treatment for Veterans With PTSDNot yet recruitingPhase 2VA Office of Research and DevelopmentNCT07904000Written as methylphenidate (MPH)
- Multimodal Brain Imaging of the Neural Effects of Methylphenidate in Patients With ADHDRecruitingPhase 4Johns Hopkins UniversityNCT04781972Written as Methylphenidate
- Oxygen Toxicity: Mechanisms in HumansRecruitingNot applicableDuke UniversityNCT05761756Written as Methylphenidate
- Evaluation of Foquest in Adults 65 Years and Older With ADHDRecruitingPhase 4Dar Clinical Research Inc.NCT07710014Written as Methylphenidate hydrochloride extended-release capsules
- Delayed-Release, Extended-Release Methylphenidate (Jornay PM) for Adolescents and Young Adults With Attention-Deficit/Hyperactivity Disorder and Cannabis Use DisorderNot yet recruitingPhase 4Massachusetts General HospitalNCT07838311Written as Delayed-release, extended-release methylphenidate
- Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity DisorderRecruitingPhase 4Donald Gilbert, MD, MS, FAAN, FAAPNCT04421248Written as Methylphenidate
- Benefits of ADHD Treatment in Detained PeopleRecruitingPhase 3Stéphanie BaggioNCT05842330Written as Concerta
- Treating Young Children With Attention Deficit Hyperactivity DisorderRecruitingPhase 4Children's Hospital Medical Center, CincinnatiNCT07300956Written as Methylphenidate (MPH)
- Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell DiseaseRecruitingPhase 1St. Jude Children's Research HospitalNCT07226219Written as Extended-Release Methylphenidate
- Methylphenidate for the Treatment of PTSD With Associated Neurocognitive ComplaintsRecruitingPhase 4VA Office of Research and DevelopmentNCT05776056Written as Methylphenidate
- The Efficacy of a Pharmacological Treatment (Reboxetine Plus Ritalin) Versus Dog-Assisted Therapy in PTSDRecruitingPhase 2University of HaifaNCT07771530Written as methylphenidate (Ritalin®)
- Efficacy of Reboxetine and Methylphenidate Treatment on Attentional, Sensory and Emotional Dysregulation in Adults With PTSDRecruitingPhase 2University of HaifaNCT05133804Written as Methylphenidate
- Methylphenidate in KBG Syndrome: N-of-1 SeriesRecruitingPhase 4Radboud University Medical CenterNCT06465641Written as Methylphenidate Hydrochloride
- Medication Treatment of ADHD in Pediatric EpilepsyRecruitingPhase 4Hugo W. Moser Research Institute at Kennedy Krieger, Inc.NCT07594652Written as methylphenidate hydrochloride (Jornay PM)
- EEG Biomarkers for ADHD Stimulant TreatmentNot yet recruitingPhase 4Boston Children's HospitalNCT07650643Written as methylphenidate HCl
- The Role of Brain Dopamine in Chronic PainRecruitingPhase 2University of RochesterNCT05285683Written as Methylphenidate
- An Open-Label Treatment With Randomization Observation, Investigator-Initiated Study, on the Duration and Efficacy of Jornay PM (Methylphenidate Hydrochloride Extended-Release Capsules) on Adult ADHD Symptoms and Executive Function and Emotional Regulation Throughout the Day Into Early EveningRecruitingPhase 4NYU Langone HealthNCT06577779Written as Methylphenidate Hydrochloride Extended Release Capsule
See all 324 studies that test Methylphenidate →
Given beside what is tested · 16 — Methylphenidate is usual care or a partner of the new treatment
- A Trial to Assess How Centanafadine Interacts With Stimulants in the BodyCompletedPhase 1Otsuka Pharmaceutical Development & Commercialization, Inc.NCT07314333Written as Methylphenidate
- Precision Functional Brain Mapping in PsilocybinCompletedEarly Phase 1Washington University School of MedicineNCT04501653Written as Methylphenidate
- Impulsivity and Stimulant AdministrationCompletedPhase 1Yale UniversityNCT01978431Written as methylphenidate
- Behavioral Effects of Drugs (Inpatient): 40 [Methamphetamine, Methylphenidate, Duloxetine]CompletedPhase 1Craig RushNCT04178993Written as Methylphenidate
- Omega-3 Fatty Acid Supplementation to ADHD Pharmacotherapy in ADHD Adults With Deficient Emotional Self-Regulation TraitsCompletedPhase 2Massachusetts General HospitalNCT01399827Written as ADHD Medication
- Cognitive Behavioral Therapy for Adolescents With Attention-Deficit / Hyperactivity DisorderStatus unknownPhase 4McGill University Health Centre/Research Institute of the McGill University Health CentreNCT02566824Written as Methylphenidate or amphetamine product
- Methylphenidate-Duloxetine Combinations for Cocaine DependenceCompletedPhase 1University of KentuckyNCT02700711Written as Methylphenidate
- L-methylfolate Supplementation to OROS-Methylphenidate Pharmacotherapy in ADHD AdultsCompletedPhase 2/3Massachusetts General HospitalNCT01853280Written as OROS-Methylphenidate
- EEG Studies of IV Methylphenidate-Induced Emergence From AnesthesiaWithdrawnPhase 1/2Massachusetts General HospitalNCT02429076Written as IV methylphenidate
- Treatment of Severe Childhood Aggression (The TOSCA Study)CompletedPhase 4Michael AmanNCT00796302Written as Methylphenidate HCl
- Psychopharmacology for Cocaine Dependence - BuspironeCompletedPhase 2The University of Texas Health Science Center, HoustonNCT01267292Written as Methylphenidate
- Prevention of Stimulant-Induced Euphoria With an Opioid Receptor AntagonistCompletedPhase 4Massachusetts General HospitalNCT01673594Written as SODAS MPH
- A Study of the Ability of Functional Magnetic Resonance Imaging (fMRI) to Detect and Characterize the Effects of Two Marketed Centrally Active Drugs, Placebo, and RO4917523 in Healthy VolunteersCompletedPhase 1Hoffmann-La RocheNCT01045083Written as methylphenidate
- A Study of Combination Therapy in Children With ADHDCompletedPhase 4Douglas SearsNCT01940978Written as Methylphenidate ER
- Memantine for Executive Dysfunction in Adults With ADHD: A Pilot StudyCompletedNot applicableMassachusetts General HospitalNCT01533493Written as OROS-Methylphenidate
- Effectiveness of Combined Medication Treatment for Aggression in Children With Attention Deficit With Hyperactivity Disorder (The SPICY Study)Status unknownPhase 4Joseph BladerNCT00794625Written as Stimulant medication
As the comparator · 20 — what is tested is compared with Methylphenidate
- Orexin s Role in the Neurobiology of Substance Use DisorderRecruitingNot applicableNational Institute on Drug Abuse (NIDA)NCT05630781Written as Methylphenidate
- Psilocybin in Chronic Low Back Pain and DepressionRecruitingPhase 1Johns Hopkins UniversityNCT06355414Written as Methylphenidate
- Cognitive Remediation in ADHD Children : Comparison Between Three Therapeutic Strategies : Cognitive Remediation With a Virtual Classroom Software and Methylphenidate and Supportive PsychotherapyCompletedNot applicableUniversity Hospital, BordeauxNCT01821170Written as Methylphenidate
- Randomized, Double-blind Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Children and Adolescents Aged 6-17CompletedPhase 3ShireNCT00763971Written as Methylphenidate Hydrochloride
- Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity DisorderCompletedPhase 4ShireNCT01552902Written as Methylphenidate Hydrochloride
- Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity DisorderCompletedPhase 4ShireNCT01552915Written as Methylphenidate Hydrochloride
- Effect of Pycnogenol® on ADHDCompletedPhase 3Nina HermansNCT02700685Written as Methylphenidate
- Efficacy of Cognitive Behavioral Therapy in Treatment of Adults With Attention Deficit Hyperactivity DisorderStatus unknownNot applicableLily HechtmanNCT02210728Written as methylphenidate or amphetamine product
- The Effectiveness of Aerobic Exercise in the Treatment of Adults With Attention Deficit Hyperactivity Disorder (ADHD)Status unknownNot applicableMcGill University Health Centre/Research Institute of the McGill University Health CentreNCT02788851Written as Methylphenidate compounds and /or Amphetamine compounds and/or Strattera or Guanfacine
- Should Chronic Stimulant Medications be Continued Preoperatively in Patients With Attention Deficit Hyperactivity Disorder(ADHD)CompletedNot applicableNationwide Children's HospitalNCT01740206Written as Amphetamine and/or methylphenidate
- Effectiveness of a Personalized Neurofeedback Training Device (ADHD@Home) in Attention-Deficit/Hyperactivity DisorderStatus unknownPhase 1/2Mensia Technologies SANCT02778360Written as Methylphenidate MPH
- Train Your Brain and Exercise Your Heart? Advancing the Treatment for Attention Deficit Hyperactivity Disorder (ADHD)CompletedPhase 2/3R. van MourikNCT01363544Written as methylphenidate
- A Study to Test the Safety and Efficacy of MK0249 in Patients With ADHD (0249-018)(COMPLETED)CompletedPhase 2Merck Sharp & Dohme LLCNCT00475735Written as Concerta (methylphenidate)
- EAA/Therapy for Treating Children With ADHDStatus unknownNot applicableSamsung Medical CenterNCT02482649Written as Methylphenidate
- A Study of Pediatric Patients With Attention Deficit/Hyperactivity DisorderCompletedPhase 2/3Eli Lilly and CompanyNCT00922636Written as Methylphenidate
- Effectiveness of Lobeline in Treating Symptoms of ADHD in Adult PatientsCompletedPhase 2Yaupon TherapeuticsNCT00664703Written as Methylphenidate HCl
- Comparing Treatment With Melatonin to Treatment With Stimulants (Methylphenidate) in Children With Attention Deficit Hyperactivity Disorder and Sleep DifficultiesStatus unknownPhase 4Assaf-Harofeh Medical CenterNCT01393574Written as Methylphenidate
- A Comparative Effectiveness Study Evaluating OROS Methylphenidate HCl, Ritalin (Methylphenidate HCl), and Placebo for the Treatment of Attention Deficit Hyperactivity Disorder in ChildrenCompletedPhase 3Alza Corporation, DE, USANCT00269789Written as Ritalin
- A Multicenter Study Comparing the Efficacy and Safety of OROS Methylphenidate HCl, Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity DisorderCompletedPhase 3Alza Corporation, DE, USANCT00269802Written as Ritalin
- Amantadine Versus Ritalin in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD)Status unknownPhase 2Tehran University of Medical SciencesNCT01099059Written as ritalin
What changed recently
From the registry's own updates since Oct 20, 2026.
Started recruiting1
- Oxygen Toxicity: Mechanisms in HumansOct 21, 2026NCT05761756
Newly registered1
- Written Exposure Therapy Plus Adjunctive Methylphenidate Treatment for Veterans With PTSDOct 29, 2026NCT07904000
Codes
What other systems call Methylphenidate · ClinicalTrials.gg INT007821
- MeSH (NLM) D008774MethylphenidateConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 207ZZ9QZ49METHYLPHENIDATEConfirmed FDA, NLM, Wikidata
- RxNorm 6901Confirmed FDA, Wikidata
- Wikidata Q422112methylphenidateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C62045MethylphenidateOne source FDA
- DrugBank DB00422One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D008774 | Methylphenidate | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 207ZZ9QZ49 | METHYLPHENIDATE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 6901 | — | Confirmed FDA, Wikidata |
| Wikidata | Q422112 | methylphenidate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C62045 | Methylphenidate | One source FDA |
| DrugBank | DB00422 | — | One source Wikidata |
Also registered as methylphenidate hydrochloride (UNII 4B3SC438HI).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.